View More View Less
  • 1 Bezmialem Vakif University, 34093 Fatih, Istanbul, Turkey

A new, sensitive, and selective high-performance liquid chromatography (HPLC) method with fluorimetric detection was developed for the determination of moxifloxacin (MOX) in human breast milk. MOX was precolumn derivatized with fluorescamine; the fluorescent derivative was separated on an RP C18 column using a mobile phase composed of acetonitrile–10 mM orthophosphoric acid by isocratic elution with flow rate of 0.5 mL min−1. The method was based on the measurement of the derivative using fluorescence detection at 481 nm with excitation at 351 nm. The calibration curve was linear over the range of 1–40 μg mL−1. Limit of detection (LOD) and limit of quantitation (LOQ) were found to be 0.3 and 1 μg mL−1, respectively. Intra-day and interday repeatabilities were less than 3.15%.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • [1]

    L.L. Brunton , B.A. Chabner, and B.C. Knollmann, Goodman and Gilman's The Pharmacological Basis of Therapeutics, McGraw-Hill Medical, 2011

    • Search Google Scholar
    • Export Citation
  • [2]

    J.K. Aranson , Moxifloxacin Meyler's Side Effects of Drugs, 16th edn., Elsevier, 2016, pp. 11291134

  • [3]

    T. Lemoine, D. Breilh, D. Ducint, J. Dubrez, J. Jougon, J.F. Velly, and M.C. Saux, J. Chromatogr. B, 742 (2), 247 (2000)

  • [4]

    A.L. Djurdjevic, M.J. Stankov, and P. Djurdjevic, J. Chromatogr. B, 844 (1), 104 (2006)

  • [5]

    A.K.H. Kumar and G. Ramachandran, J. Chromatogr. B, 877 (11–12), 1205 (2009)

  • [6]

    J. Sousa, G. Alves, G. Campos, A. Fortuna, and A. Falcão, J. Chromatogr. B, 930 (1), 104 (2013)

  • [7]

    Y.H. Xu, D. Li, X.Y. Liu, Y.Z. Li, and J. Lu, J. Chromatogr. B, 878 (32), 3437 (2010)

  • [8]

    K.P. Chan, K.O. Chu, W.W. Kwan Lai , K.W. Choy, C.C. Wang, D.S. Chiu Lam, and C.P. Pang, Anal. Biochem., 353 (1), 30 (2006)

  • [9]

    H.A. Nguyen , J. Grellet, B.B. Ba, C. Quentin, and M.C. Saux, J. Chromatogr. B, 810 (1), 77, 2004

  • [10]

    K. Vishwanathan, M.G. Bartlett, and J.T. Stewart, J. Pharm. and Biomed. Anal., 30 (4), 961 (2002)

  • [11]

    H. Liang, M.B. Kays, and K.M. Sowinski, J. Chromatogr. B, 772 (1), 53 (2002)

  • [12]

    M.A.G. Trindade, G.M. Silva, and V.S. Ferreira, Microchem J,. 81 (2), 209 (2005)

  • [13]

    J.G. Möller , H. Staß, R. Heinig, and G. Blaschke, J. Chromatogr. B, 716 (1–2), 325 (1998)

  • [14]

    S. Padberg , Anti-infectives, Drugs During Pregnancy and Lactation, 3rd edn., 2015, pp. 687703

  • [15]

    S. Stein, P. Bohlen, J. Stone, W. Dairman, and Undenfriend, S. Arch. Biochem. Biophys. 155 (1), 203 (1973)

  • [16]

    M. Douša, P. Gibala, and K. Lemr, J. Pharm. Biomed. Anal., 53 (3), 717 (2010)

  • [17]

    X. Huang , X.F. Guo, H. Wang, and H.S. Zhang, Arabian J. Chem., In Press, Corrected Proof, available online December 2014

  • [18]

    X. Huang and M. Hernick, Anal. Biochem. 414 (2), 278 (2011)

  • [19]

    P. Job, Anal. Chem. 9, 113 (1928)

  • [20]

    Text on validation of analytical procedures Q2A, Technical requirements for registration of pharmaceuticals for human use. International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use, Geneva, 2005

    • Search Google Scholar
    • Export Citation

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Nov 2020 0 2 1
Dec 2020 0 3 3
Jan 2021 0 1 0
Feb 2021 0 4 5
Mar 2021 0 2 0
Apr 2021 0 1 1
May 2021 0 0 0